← Back to patent-cliff list
CAS 2162-31-4
2-((tetrahydro-2H-pyran-2-yl)oxy)ethan-1-ol
Codes: BOSE-010
Application context (from source-drug indications)
溃疡Bosentan HydratePulmonary arterial hypertensionBosentan HydratePulmonary hypertensionBosentan HydrateSystemic sclerosisBosentan Hydrate冠状血管痉挛Bosentan Hydrate大动脉炎Bosentan Hydrate
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Bosentan Hydrate | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
4,6-dichloro-5-(2-methoxyphenoxy)-2,2'-bipyrimidine→4-(tert-butyl)benzenesulfonamide→2-((tetrahydro-2H-pyran-2-yl)oxy)ethan-1-ol→4-chloro-5-(2-methoxyphenoxy)-6-(2-((tetrahydro-2H-pyran-2-yl)oxy)ethoxy)-2,2'-bipyrimidine→4-(tert-butyl)-N-(5-(2-methoxyphenoxy)-6-(2-((tetrahydro-2H-pyran-2-yl)oxy)ethoxy)-[2,2'-bipyrimidin]-4-yl)benzenesulfonamide
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.